Antibodies against endothelial cells in patients with multiple sclerosis

Acta Neurologica Scandinavica

Volumn 93, Issue 6, 1996, Pages 416-420

  Tintore, M ^a,d   Fernandez, A L ^a   Rovira, A ^b   Martinez, X ^a   Direskeneli, H ^c   Khamashta, M ^c   Schwartz, S ^a   Codina, A ^a   Montalban, X ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Institut de Diagnostic per la Imatge   (Spain)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d Unitat de Neuroinvestigacio   (Spain)

Author keywords

Cytokine; Endothelial cell; MRI; Multiple sclerosis; Pathogenesis

Indexed keywords

ANTIBODY; BETA INTERFERON; GADOLINIUM; GAMMA INTERFERON;

ADOLESCENT; ADULT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030054753     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb00020.x     Document Type: Article

References (18)

1. COMPSTON A. Immunological aspects of multiple sclerosis. In: MATTHEWS WB, COMPSTON A, ALLEN IV, MARTYN CN, eds. McAlpine's multiple sclerosis. Edinburgh: Churchill Livingstone, 1991: 321-339.
2. BROMAN T. Blood-brain barrier damage in multiple sclerosis. Supra-vital test observations. Acta Neurol Scand 1964: 40(suppl 10): 21-24.
3. BROWN WJ. The capillaries in acute and subacute multiple sclerosis plaques: a morphometric analysis. Neurology 1978: 28: 84-92.
4. MILLER DH, RUDGE P, JONHSON G et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988: 111: 927-939.
5. CHARCOT JM. Oeuvres Complètes Tome I: Leçons sur les maladies du système nerveux. Bureaux du progrès médicale et Louis Bataille, editeur, Paris.
6. GRAHAM EM, FRANCIS DA, SANDERS MD, RUDGE P. Ocular inflammatory changes in established multiple sclerosis. J Neurol Neurosurg Psychiatry 1989: 52: 1360-1363.
7. DHIB-JALBUT S, MC FARLIN DE. Immunology of multiple sclerosis. Ann Allergy 1990: 64: 433-444.
8. TANAKA Y, TSUKADA N, KOH CH-S, YANAGISAWA N. Anti-endothelial cell antibodies and circulating immune complexes in the sera of patients with multiple sclerosis. J Neuroimmunol 1987: 17: 49-59.
9. SOUBERBIELLE BE, SWINGLER RJ, DAVIDSON DLW, et al. Western blotting analysis in patients with MS using human brain vessels as antigen. Acta Neurol Scand 1992: 86: 397-402.
10. POSER CM, PATY DW, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis: guidelines for research proposals. Ann Neurol 1983: 13: 227-231.
11. KURTZKE JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983: 33: 1444-1452.
12. TAN EM, COHEN AS, FRIES JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982: 25: 1271-1280.
13. JAFFE EA, NACHMAN RL, BECKER CG, MINICK CR. The culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologie criteria. J Clin Invest 1973: 52: 2745-2756.
14. YOUINOU P, MERONI PL, KHAMASHTA MA, SHOENFELD Y. A need for standardization of the anti-endothelial-cell antibody test. Immunol Today 1995: 16: 363-364.
15. GRABAR P. Autoantibodies and the physiological role of immunoglobulins. Immunol Today 1983: 4: 337-340.
16. LEUNG DYM, COLLINS T, LAPIERRE LA, GEHA RS, POBER JS. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 1986: 77: 1428-1435.
17. STERNBERGER NH, STERNBERGER LA. Blood brain barrier protein recognized by monoclonal antibody. PNAS USA 1987: 84: 8169-8173.
18. SEULBERGER H, RISAU W. Molecular cloning of a blood brain barrier cell surface glycoprotein. In: Pardridge WM, ed.The blood brain barrier cellular and molecular biology. New York: Raven Press 1993: 369-393.